DOCSLIB.ORG

Code Description Fee 10021 Fine Needle Aspiration

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Code Description Fee 10021 Fine Needle Aspiration Code Description Fee 10021 Fine needle aspiration; without imaging guidance $3,035.35 10030 Image-guided fluid collection drainage by catheter (eg, abscess, hematoma, $6,025.57 seroma, lymphocele, cyst), soft tissue (eg, extremity, abdominal wall, neck), percutaneous 10035 Placement of soft tissue localization device(s) (eg, clip, metallic pellet, $5,795.10 wire/needle, radioactive seeds), percutaneous, including imaging guidance; first lesion 10036 Placement of soft tissue localization device(s) (eg, clip, metallic pellet, $3,749.08 wire/needle, radioactive seeds), percutaneous, including imaging guidance; each additional lesion (List separately in addition to code for primary procedure) 10040 Acne surgery (eg, marsupialization, opening or removal of multiple milia, $1,659.94 comedones, cysts, pustules) 10060 Incision and drainage of abscess (eg, carbuncle, suppurative hidradenitis, $1,659.94 cutaneous or subcutaneous abscess, cyst, furuncle, or paronychia); simple or single 10061 Incision and drainage of abscess (eg, carbuncle, suppurative hidradenitis, $3,035.35 cutaneous or subcutaneous abscess, cyst, furuncle, or paronychia); complicated or multiple 10080 Incision and drainage of pilonidal cyst; simple 10081 Incision and drainage of pilonidal cyst; complicated 10120 Incision and removal of foreign body, subcutaneous tissues; simple $3,035.35 10121 Incision and removal of foreign body, subcutaneous tissues; complicated 10140 Incision and drainage of hematoma, seroma or fluid collection $13,039.70 10160 Puncture aspiration of abscess, hematoma, bulla, or cyst 10180 Incision and drainage, complex, postoperative wound infection 11000 Debridement of extensive eczematous or infected skin; up to 10% of body $4,721.69 surface 11001 Debridement of extensive eczematous or infected skin; each additional 10% $231.42 of the body surface, or part thereof (List separately in addition to code for primary procedure) 11004 Debridement of skin, subcutaneous tissue, muscle and fascia for necrotizing $5,821.79 soft tissue infection; external genitalia and perineum 11005 Debridement of skin, subcutaneous tissue, muscle and fascia for necrotizing $7,953.50 soft tissue infection; abdominal wall, with or without fascial closure 11006 Debridement of skin, subcutaneous tissue, muscle and fascia for necrotizing $7,159.77 soft tissue infection; external genitalia, perineum and abdominal wall, with or without fascial closure 11008 Removal of prosthetic material or mesh, abdominal wall for infection (eg, $2,797.94 for chronic or recurrent mesh infection or necrotizing soft tissue infection) (List separately in addition to code for primary procedure) 11010 Debridement including removal of foreign material at the site of an open $5,795.10 fracture and/or an open dislocation (eg, excisional debridement); skin and subcutaneous tissues 11011 Debridement including removal of foreign material at the site of an open $5,795.10 fracture and/or an open dislocation (eg, excisional debridement); skin, subcutaneous tissue, muscle fascia, and muscle 11012 Debridement including removal of foreign material at the site of an open $22,029.46 fracture and/or an open dislocation (eg, excisional debridement); skin, subcutaneous tissue, muscle fascia, muscle, and bone 11042 Debridement, subcutaneous tissue (includes epidermis and dermis, if $3,035.35 performed); first 20 sq cm or less 11043 Debridement, muscle and/or fascia (includes epidermis, dermis, and $4,721.69 subcutaneous tissue, if performed); first 20 sq cm or less 11044 Debridement, bone (includes epidermis, dermis, subcutaneous tissue, $13,039.70 muscle and/or fascia, if performed); first 20 sq cm or less 11045 Debridement, subcutaneous tissue (includes epidermis and dermis, if $412.68 performed); each additional 20 sq cm, or part thereof (List separately in addition to code for primary procedure) 11046 Debridement, muscle and/or fascia (includes epidermis, dermis, and $736.73 subcutaneous tissue, if performed); each additional 20 sq cm, or part thereof (List separately in addition to code for primary procedure) 11047 Debridement, bone (includes epidermis, dermis, subcutaneous tissue, $1,228.35 muscle and/or fascia, if performed); each additional 20 sq cm, or part thereof (List separately in addition to code for primary procedure) 11055 Paring or cutting of benign hyperkeratotic lesion (eg, corn or callus); single $1,659.94 lesion 11056 Paring or cutting of benign hyperkeratotic lesion (eg, corn or callus); 2 to 4 $1,659.94 lesions 11057 Paring or cutting of benign hyperkeratotic lesion (eg, corn or callus); more $1,659.94 than 4 lesions 11200 Removal of skin tags, multiple fibrocutaneous tags, any area; up to and $1,659.94 including 15 lesions 11201 Removal of skin tags, multiple fibrocutaneous tags, any area; each $183.45 additional 10 lesions, or part thereof (List separately in addition to code for primary procedure) 11300 Shaving of epidermal or dermal lesion, single lesion, trunk, arms or legs; $1,659.94 lesion diameter 0.5 cm or less 11301 Shaving of epidermal or dermal lesion, single lesion, trunk, arms or legs; $1,659.94 lesion diameter 0.6 to 1.0 cm 11302 Shaving of epidermal or dermal lesion, single lesion, trunk, arms or legs; $1,659.94 lesion diameter 1.1 to 2.0 cm 11303 Shaving of epidermal or dermal lesion, single lesion, trunk, arms or legs; $3,035.35 lesion diameter over 2.0 cm 11305 Shaving of epidermal or dermal lesion, single lesion, scalp, neck, hands, $1,659.94 feet, genitalia; lesion diameter 0.5 cm or less 11306 Shaving of epidermal or dermal lesion, single lesion, scalp, neck, hands, $1,659.94 feet, genitalia; lesion diameter 0.6 to 1.0 cm 11307 Shaving of epidermal or dermal lesion, single lesion, scalp, neck, hands, $1,659.94 feet, genitalia; lesion diameter 1.1 to 2.0 cm 11308 Shaving of epidermal or dermal lesion, single lesion, scalp, neck, hands, $3,035.35 feet, genitalia; lesion diameter over 2.0 cm 11310 Shaving of epidermal or dermal lesion, single lesion, face, ears, eyelids, $1,659.94 nose, lips, mucous membrane; lesion diameter 0.5 cm or less 11311 Shaving of epidermal or dermal lesion, single lesion, face, ears, eyelids, $1,659.94 nose, lips, mucous membrane; lesion diameter 0.6 to 1.0 cm 11312 Shaving of epidermal or dermal lesion, single lesion, face, ears, eyelids, $3,035.35 nose, lips, mucous membrane; lesion diameter 1.1 to 2.0 cm 11313 Shaving of epidermal or dermal lesion, single lesion, face, ears, eyelids, $3,035.35 nose, lips, mucous membrane; lesion diameter over 2.0 cm 11400 Excision, benign lesion including margins, except skin tag (unless listed $5,795.10 elsewhere), trunk, arms or legs; excised diameter 0.5 cm or less 11401 Excision, benign lesion including margins, except skin tag (unless listed $3,035.35 elsewhere), trunk, arms or legs; excised diameter 0.6 to 1.0 cm 11402 Excision, benign lesion including margins, except skin tag (unless listed $5,795.10 elsewhere), trunk, arms or legs; excised diameter 1.1 to 2.0 cm 11403 Excision, benign lesion including margins, except skin tag (unless listed $5,795.10 elsewhere), trunk, arms or legs; excised diameter 2.1 to 3.0 cm 11404 Excision, benign lesion including margins, except skin tag (unless listed $13,039.70 elsewhere), trunk, arms or legs; excised diameter 3.1 to 4.0 cm 11406 Excision, benign lesion including margins, except skin tag (unless listed $13,039.70 elsewhere), trunk, arms or legs; excised diameter over 4.0 cm 11420 Excision, benign lesion including margins, except skin tag (unless listed $13,039.70 elsewhere), scalp, neck, hands, feet, genitalia; excised diameter 0.5 cm or less 11421 Excision, benign lesion including margins, except skin tag (unless listed $5,795.10 elsewhere), scalp, neck, hands, feet, genitalia; excised diameter 0.6 to 1.0 cm 11422 Excision, benign lesion including margins, except skin tag (unless listed $13,039.70 elsewhere), scalp, neck, hands, feet, genitalia; excised diameter 1.1 to 2.0 cm 11423 Excision, benign lesion including margins, except skin tag (unless listed $13,039.70 elsewhere), scalp, neck, hands, feet, genitalia; excised diameter 2.1 to 3.0 cm 11424 Excision, benign lesion including margins, except skin tag (unless listed $13,039.70 elsewhere), scalp, neck, hands, feet, genitalia; excised diameter 3.1 to 4.0 cm 11426 Excision, benign lesion including margins, except skin tag (unless listed $22,029.46 elsewhere), scalp, neck, hands, feet, genitalia; excised diameter over 4.0 cm 11440 Excision, other benign lesion including margins, except skin tag (unless $5,795.10 listed elsewhere), face, ears, eyelids, nose, lips, mucous membrane; excised diameter 0.5 cm or less 11441 Excision, other benign lesion including margins, except skin tag (unless $5,795.10 listed elsewhere), face, ears, eyelids, nose, lips, mucous membrane; excised diameter 0.6 to 1.0 cm 11442 Excision, other benign lesion including margins, except skin tag (unless $5,795.10 listed elsewhere), face, ears, eyelids, nose, lips, mucous membrane; excised diameter 1.1 to 2.0 cm 11443 Excision, other benign lesion including margins, except skin tag (unless $13,039.70 listed elsewhere), face, ears, eyelids, nose, lips, mucous membrane; excised diameter 2.1 to 3.0 cm 11444 Excision, other benign lesion including margins, except skin tag (unless $13,039.70 listed elsewhere), face, ears, eyelids, nose, lips, mucous membrane; excised diameter 3.1 to 4.0 cm 11446 Excision, other benign lesion including margins, except skin tag (unless $22,029.46 listed elsewhere), face, ears, eyelids, nose, lips, mucous
Load more

Recommended publications
  • Lower Gastrointestinal Bleeding
    Journal of Experimental and Clinical Medicine https://dergipark.org.tr/omuJecm Re view Article J Exp Clin Med 2021; 38(S1): 23-32 doi: 10.52142/omujecm.38.si.gastro.3 Lower gastrointestinal bleeding Serkan ÖCAL1,* , Mehmet Mutlu ÇATLI2 1 Department of Gastroenterology, University of Health Sciences Antalya Training and Research Hospital, Antalya, Turkey 2Departmant of Internal Medicine, Antalya Training and Research Hospital, Antalya, Turkey Received: 13.12.2020 • Accepted/Published Online: 09.01.2021 • Final Version: 18.03.2021 Abstract Bleeding from the lower part of the digestive system that appears as hematocheZia (fresh blood, clot or cherry-colored stool) or melena (dark- colored tarry stool) is called lower gastrointestinal tract bleeding (lower GI bleeding) (or colonic bleeding). In the traditional definition, lower GI bleeding was generally classified as bleeding distal to the TreitZ ligament (duodenojejunal junction) as the border. In the last decade, GI bleeding has adopted three categories in some recent publications: Upper, middle, and lower. According to this category, bleeding from a source between the TreitZ ligament and the ileocecal valve is classified as middle GI bleeding, bleeding from the distal of the ileocecal valve is classified lower GI bleeding. Lower GI bleeding and hospitalization rates increase with aging. Currently, physicians managing lower GI bleeding have many different diagnostic and therapeutic options ranging from colonoscopy and flexible sigmoidoscopy to radiographic interventions such as scintigraphy or angiography. Lower GI bleeding often stops spontaneously and less common than upper GI bleeding. Even though no modality has emerged as the gold standard in the treatment of lower GI bleeding, colonoscopy has several advantages and is generally considered as the preferred initial test in most of the cases.
    [Show full text]
  • Otoplasty-Plastic Surgery of the Ears (Pdf)
    Vinod K. Anand, MD, FACS Nose and Sinus Clinic Plastic Surgery of the Ears (Otoplasty) This brochure will familiarize you with some basic facts about cosmetic surgery of the ear. It will give you enough general background to make you an "educated consumer." Your facial plastic surgeon will explain how this procedure applies to an individual's condition. A SOLUTION FOR A VERY COMMON PROBLEM The most common cosmetic problem that people have with their ears is that they pro- trude. Otoplasty is the name given to the operation designed to "pin back" the ears and to change their shape and contour. While otoplasty can be performed at any age after four or five years, it often is recom- mended in the preschool years to alleviate possible teasing at school by other children. DECIDING ON AN OPERATION Anyone interested in cosmetic surgery of the ear for himself or a child should consult a competent facial plastic surgeon. During the initial visit, the surgeon makes a thorough evaluation of the ears to determine whether surgery is indicated. The surgeon will then discuss any questions and concerns related to the surgery. In addition to the skill of the surgeon, the patient's realistic expectations about the results of the surgery and his general emotional state are important considerations. Mental attitude is as important as the ability to heal in evaluating candidates for facial plastic surgery. Once surgery is agreed upon, pre-operative photographs are taken to help the surgeon plan the operation. These photographs usually are compared with similar ones taken sometime after surgery and serve as a permanent before-and-after record of the results.
    [Show full text]
  • National Correct Coding Initiative Policy Manual for Medicare Services Revision Date: 1/1/2019
    National Correct Coding Initiative Policy Manual for Medicare Services Revision Date: 1/1/2019 Current Procedural Terminology (CPT) codes, descriptions and other data only are copyright 2018 American Medical Association. All rights reserved. CPT® is a registered trademark of the American Medical Association. Applicable FARS\DFARS Restrictions Apply to Government Use. Fee schedules, relative value units, conversion factors, prospective payment systems, and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for the data contained or not contained herein. TABLE OF CONTENTS FOR NATIONAL CORRECT CODING INITIATIVE POLICY MANUAL FOR MEDICARE SERVICES Introduction Introduction Intro-3 Purpose Intro-3 Policy Manual Background Intro-6 Edit Development and Review Process Intro-7 Sources of Information about NCCI and MUE Intro-9 Correspondence to CMS about NCCI and its Contents Intro-10 Chapter I - General Correct Coding Policies List of Acronyms I-3 A. Introduction I-5 B. Coding Based on Standards of Medical/Surgical I-9 Practice C. Medical/Surgical Package I-12 D. Evaluation and Management (E&M) Services I-17 E. Modifiers and Modifier Indicators I-19 F. Standard Preparation/Monitoring Services for I-27 Anesthesia G. Anesthesia Service Included in the Surgical Procedure I-27 H. HCPCS/CPT Procedure Code Definition I-28 I. CPT Manual and CMS Coding Manual Instructions I-29 J. CPT “Separate Procedure” Definition I-30 K. Family of Codes I-30 L.
    [Show full text]
  • Outpatient Services
    Outpatient Services Coverage of Certain Services in the OUTPATIENT setting only* EFFECTIVE MARCH 9, 2015 bmchp.org | 888-566-0008 TO FIND A CODE OR WORD - While holding down the CTRL key, press the F key, type in Code, then press ENTER key Procedure Code Description 0213T Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with ultrasound guidance, cervical or thoracic; single level 0214T Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with ultrasound guidance, cervical or thoracic; second level (List separately in addition to code for primary procedure) 0215T Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with ultrasound guidance, cervical or thoracic; third and any additional level(s) (List separately in addition to code for primary procedure) 0216T Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with ultrasound guidance, lumbar or sacral; single level 0217T Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with ultrasound guidance, lumbar or sacral; second level (List separately in addition to code for primary procedure) 0218T Injection(s), diagnostic or therapeutic agent, paravertebral facet (zygapophyseal) joint (or nerves innervating that joint) with ultrasound
    [Show full text]
  • Anatomical Overview
    IKOdontogenetic infection is spreaded Možné projevy zlomenin a zánětů IKPossible signs of fractures or inflammations Submandibular space lies between the bellies of the digastric muscles, mandible, mylohyoid muscle and hyoglossus and styloglossus muscles IK IK IK IK IK Submandibulární absces Submandibular abscess IK Sběhlý submandibulární absces Submandibular abscess is getting down IK Submental space lies between the mylohyoid muscles and the investing layer of deep cervical fascia superficially IK IK Spatium peritonsillare IK IK Absces v peritonsilární krajině Abscess in peritonsilar region IK Fasciae Neck fasciae cervicales Demarcate spaces • fasciae – Superficial (investing): • f. nuchae, f. pectoralis, f. deltoidea • invests m. sternocleidomastoideus + trapezius • f. supra/infrahyoidea – pretrachealis (middle neck f.) • form Δ, invests infrahyoid mm. • vagina carotica (carotic sheet) – Prevertebral (deep cervical f.) • Covers scaleni mm. IK• Alar fascia Fascie Fascia cervicalis superficialis cervicales Fascia cervicalis media Fascia cervicalis profunda prevertebralis IKsuperficialis pretrachealis Neck spaces - extent • paravisceral space – Continuation of parafaryngeal space – Nervous and vascular neck bundle • retrovisceral space – Between oesophagus and prevertebral f. – Previsceral space – mezi l. pretrachealis a orgány – v. thyroidea inf./plx. thyroideus impar • Suprasternal space – Between spf. F. and pretracheal one IK– arcus venosus juguli 1 – sp. suprasternale suprasternal Spatia colli 2 – sp. pretracheale pretracheal 3 –
    [Show full text]
  • The Posterior Muscles of the Auricle: Anatomy and Surgical Applications
    Central Annals of Otolaryngology and Rhinology Research Article *Corresponding author Christian Vacher, Department of Maxillofacial Surgery & Anatomy, University of Paris-Diderot, APHP, 100, The Posterior Muscles of the Boulevard Général Leclerc, 92110 Clichy, France, Tel: 0033140875671; Email: Submitted: 19 December 2014 Auricle: Anatomy and Surgical Accepted: 16 January 2015 Published: 19 January 2015 Applications Copyright © 2015 Vacher et al. Rivka Bendrihem1, Christian Vacher2* and Jacques Patrick Barbet3 OPEN ACCESS 1 Department of Dentistry, University of Paris-Descartes, France Keywords 2 Department of Maxillofacial Surgery & Anatomy, University of Paris-Diderot, France • Auricle 3 Department of Pathology and Cytology, University of Paris-Descartes, France • Anatomy • Prominent ears Abstract • Muscle Objective: Prominent ears are generally considered as primary cartilage deformities, but some authors consider that posterior auricular muscles malposition could play a role in the genesis of this malformation. Study design: Auricle dissections of 30 cadavers and histologic sections of 2 fetuses’ ears. Methods: Posterior area of the auricle has been dissected in 24 cadavers preserved with zinc chlorure and 6 fresh cadavers in order to describe the posterior muscles and fascias of the auricle. Posterior auricle muscles from 5 fresh adult cadavers have been performed and two fetal auricles (12 and 22 weeks of amenorhea) have been semi-serially sectioned in horizontal plans. Five µm-thick sections were processed for routine histology (H&E) or for immuno histochemistry using antibodies specific for the slow-twitch and fast-twich myosin heavy chains in order to determine which was the nature of these muscles. Results: The posterior auricular and the transversus auriculae muscles looked in most cases like skeletal muscles and they were made of 75% of slow muscular fibres.
    [Show full text]
  • Otolaryngology Head & Neck Surgery Residency Manual
    OTOLARYNGOLOGY HEAD & NECK SURGERY RESIDENCY MANUAL Carol A Bauer, MD –Professor and Chair, Residency Program Director Dana L Crosby, MD – Associate Program Director Sandra Ettema, MD, PhD – Associate Program Director Jenny Kesselring, C-TAGME - Residency Program Coordinator (217-545-4777) Updated 6/21/2017 TABLE OF CONTENTS INTRODUCTION ............................................................................................................................ 2 ADMINISTRATIVE INFORMATION .................................................................................................. 3 GENERAL EXPECTATIONS OF OTOLARYNGOLOGY RESIDENTS ..................................................... 3 CHIEF RESIDENT EXPECTATIONS AND RESPONSIBILITIES ............................................................ 8 OTOLARYNGOLOGY DUTY HOUR POLICY .................................................................................. 11 TRAVEL POLICY ......................................................................................................................... 13 VACATION / LEAVE OF ABSENCE POLICY .................................................................................. 15 OVERVIEW OF EDUCATIONAL GOALS, OBJECTIVES AND COMPETENCIES .................................. 21 THE CURRICULUM GUIDE .......................................................................................................... 25 TEACHING GOALS AND OBJECTIVES .......................................................................................... 28 RESEARCH GOALS AND
    [Show full text]
  • FAQ Document
    The Society of Thoracic Surgeons Frequently Asked Questions: General Thoracic Database Version 2.07 December 2008 How to use the “interactive” FAQ Document: 1. To review all clinical questions in an individual section, click on the section title below. Section A: seq# 10 - 190 Section C: seq# 285 - 650 Section E: seq# 770 - 1210 Section B: seq# 200 - 260 Section D: seq# 660 - 750 Section F: seq# 1220 - 1340 2. To review an individual Seq# clinical question, click on the Seq# title below. Participation in both General Thoracic and Adult Cardiac Databases GENERAL STATEMENT #2 Seq# 200: Zubrod Score Seq# 775: Postop Events Seq# 300: WtLoss3Kg Seq# 860: Pneumonia Seq# 310: Category of disease Seq# 930: Other Pulmonary Event Seq# 390: PreOp Chemotherapy Seq# 940: Atrial Arrhythmia Seq# 400: PreOp Thoracic RT Seq# 1020: Anastomotic leak Seq# 430: Other Cormorbidity Seq# 1190: Empyema Seq# 540: Clinical Stage Not Applicable (2.06) Seq# 1200: Other event req. Rx Seq# 725: Reoperation Seq# 1250: 30 Day Status Seq# 740: Procedure Seq# 1280: Chest Tube Out Date Seq# 750: Primary Procedure Seq# 751: Thoracoscopy Approach NEW Date SeqNo FieldName Definition 3/06 Participation in both General We participate in both Adult Cardiac and Yes, enter into both. In the Adult Cardiac DB, the Thoracic and Adult Cardiac General Thoracic Database. Our question primary procedure would be Seq# 1310 pertains to whether the patient should end up OpOCard=Yes; Seq# 2510 ONCAoAn=Yes; Databases in both databases. Scenario--We had a Seq# 2530 ONCArch=Yes; Seq# 2540 patient who had an aortic aneurysm repair ONCDesc=Yes; Seq# 3220 Readm30=Yes; (arch/descending thoracic) and was entered Seq# ReadmRsn=either Pneumonia or other into the Adult Cardiac Database.
    [Show full text]
  • Toman's Tuberculosis Case Detection, Treatment, and Monitoring
    TOMAN’S TUBERCULOSIS TOMAN’S TUBERCULOSIS CASE DETECTION, TREATMENT, AND MONITORING The second edition of this practical, authoritative reference book provides a rational basis for the diagnosis and management of tuberculosis. Written by a number of experts in the field, it remains faithful to Kurt Toman’s original question-and-answer format, with subject matter grouped under the three headings Case detection, Treatment, and Monitoring. It is a testament to the enduring nature of the first edition that so much CASE DETECTION, TREA material has been retained unchanged. At the same time, the new edition has had not only to address the huge resurgence of tuber- culosis, the emergence of multidrug-resistant bacilli, and the special needs of HIV-infected individuals with tuberculosis, but also to encompass significant scientific advances. These changes in the profile of the disease and in approaches to management have inevitably prompted many new questions and answers and given a different complexion to others. Toman’s Tuberculosis remains essential reading for all who need to AND MONITORING TMENT, QUESTIONS learn more about every aspect of tuberculosis – case-finding, manage- ment, and effective control strategies. It provides invaluable support AND to anyone in the front line of the battle against this disease, from ANSWERS programme managers to policy-makers and from medical personnel to volunteer health workers. SECOND EDITION ISBN 92 4 154603 4 WORLD HEALTH ORGANIZATION WHO GENEVA Toman’s Tuberculosis Case detection, treatment, and monitoring – questions and answers SECOND EDITION Edited by T. Frieden WORLD HEALTH ORGANIZATION GENEVA 2004 WHO Library Cataloguing-in-Publication Data Toman’s tuberculosis case detection, treatment, and monitoring : questions and answers / edited by T.
    [Show full text]
  • 114.3 Cmr: Division of Health Care Finance and Policy Ambulatory Care
    114.3 CMR: DIVISION OF HEALTH CARE FINANCE AND POLICY AMBULATORY CARE 114.3 CMR 40.00: RATES FOR SERVICES UNDER M.G.L. c. 152, WORKERS’ COMPENSATION ACT Section 40.01: General Provisions 40.02: General Definitions 40.03: Service and Rate Coverage Provisions 40.04: Provisions Affecting Eligible Providers 40.05: Policies for Individual Service Types 40.06: Fees 40.07: Appendices 40.08: Severability 40.01: General Provisions (1) Scope, Purpose and Effective Date. 114.3 CMR 40.00 governs the payment rates effective April 1, 2009 for purchasers of health care services under M.G.L. c. 152, the Workers’ Compensation Act. Payment rates for services provided by hospitals are set forth in 114.1 CMR 41.00. Program policies relating to medical necessity and clinical appropriateness are determined pursuant to M.G.L. c. 152 and 452 CMR 6.00. (2) Coverage. The payment rates set forth in 114.3 CMR 40.06 are full payment for services provided under M.G.L. c. 152, § 13, including any related administrative or overhead costs. The insurer, employer and health care service provider may agree upon a different payment rate for any service set forth in the fee schedule in 114.3 CMR 40.00. No employee may be held liable for the payment for health care services determined compensable under M.G.L. c. 152, § 13. (3) Administrative Bulletins. The Division may issue administrative bulletins to clarify substantive provisions of 114.3 CMR 40.00, or to publish procedure code updates and corrections. For coding updates and correction, the bulletin will list: (a) new code numbers for existing codes, with the corresponding cross references between existing and new codes numbers; (b) deleted codes for which there are no corresponding new codes; and (c) codes for entirely new services that require pricing.
    [Show full text]
  • Flexible Video-Endsocopic Injection Sclerotherapy for Second and Third Degree Internal Hemorrhoids
    Published online: 2019-09-26 ORIGINAL ARTICLE Flexible Video-Endsocopic Injection Sclerotherapy for Second and Third Degree Internal Hemorrhoids Sandeep Nijhawan, Udawat H, Gaurav Gupta, Anil Sharma, Amit Mathur, Bharat Sapra, Subhash Nepalia Department of Gastroenterology, SMS Medical College, Jaipur, Rajasthan, India ABSTRACT Background and objectives: Bleeding from hemorrhoids is the commonest cause of rectal bleeding in adults. Injection sclerotherapy of internal hemorrhoids is one of the non-surgical treatments, and is simple, safe and feasible. Conventionally sclerotherapy is performed with rigid proctoscope which has limitations of maneuverability, narrower field of vision and documentation compared to flexible videoendoscope. Therefore, we assessed the efficacy and safety of video-colonoscopic sclerotherapy for bleeding internal hemorrhides. Methods: Seventy-nine patients of bleeding internal hemorrhoids were subjected to colonoscopic sclerotherapy using 1.5% polidocanol in retroflexed or forward viewing positions. Success of treatment was defined as cessation of bleeding for six weeks. Patients were observed for complications and were followed up regularly for 3 months. Results: A total of 79 evaluable patients, 61 had grade II and 18 had grade III hemorrhoids. There was no statistically significant differences in achieving excellent or good results for control of bleeding between patients with grade II and grade III hemorrhoids (100% vs 94,5%; p>0.05). The number of sessions of sclerotherapy required were significantly more in grade II than grade III hemorrhoids (1.1 ± 0.3 vs 1.3 ± 0.7; p = 0.04). No significant complications were noted except for bloating in ten patients (12.6 %) and rectal pain in 6 (7.6%) patients.
    [Show full text]
  • Otoplasty in an Operation Performed to Reduce One Or Both Prominent Ears
    What is an otoplasty? Otoplasty in an operation performed to reduce one or both prominent ears. Children with prominent ears have excess cartilage in the bowl or concha that protruded the ear out away from the skull. They also have a missing fold called the antihelical crus in the upper part of the ear that further directs the ear out away from the head. 1:1000 children born in the US have this problem. What age is surgery performed? Surgery is typically performed at age 5-6 years, but any time after age 5 is ok. Surgery performed before age 5 is rare due to concerns about ear growth after the operation. What should be done before surgery? A recent history and physical documenting good health is required one week or less before the surgery. No lab tests are required except in special circumstances. No eating or drinking after midnight, the night before the operation unless otherwise instructed . How is the operation performed? There are many types of otoplasty procedures. They range from simple cartilage to removals, to otobrasion, to complex grafting and tissue rearrangements. In our practice all the various procedures are performed based on the need of the patient. However, the most common type of otoplasty we use is the Lucket Otoplasty. This procedure involves 4 parts. • 1. Skin reduction • 2. Concha bowl reduction • 3. Concha-mastoid suturing • 4. Sculpting of the antihelical fold in the flattened upper quadrant of the ear How long is the surgery? The surgery typically takes 1 hour per ear depending of the degree of severity.
    [Show full text]